Clinical Trials Browser

INDUSTRY × Sezary Syndrome × mogamulizumab × Clear all

NCT07132567 2025-09-22

Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance

Mycosis Fungoides, Sezary Syndrome

NCT05455931 2024-09-04

PROSPER

Active not recruiting

Mycosis Fungoides, Sezary Syndrome

NCT01728805 2024-04-25

Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL

Phase 3 Completed

372 enrolled 14 charts 1 FDA

DermatologicLymphoid

Sezary Syndrome, Lymphoma, T-Cell, Cutaneous